Clin2
NCT07379463Likely a fitRecruiting

PET/CT imaging study for people with cancer

Amino-Acid Transport DisorderPrimary HyperparathyroidismGlioma

Part of Cancer, Hormones & metabolism clinical trials.

This study uses a special PET/CT scan to look at amino acid transporters in tumors. It may help doctors better understand and diagnose certain cancers.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
500 people
Ages
18 years to 90 years
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You have suspected or known cancer (based on tests like MRI, CT, or biopsy).
  • You have been scheduled for an AATS PET/CT scan as part of your care.
  • You or your legal representative can sign a consent form.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06690983Recruiting
Tau PET/CT scan study for people with related diseases

This study uses a special scan (Tau PET/CT) to look at tau protein in the brain or body. It may help doctors understand tau-related diseases better, and is open to adults who are scheduled for this scan.

Hefei, Anhui
NCT06688071Recruiting
FAPI PET/CT scan for people with cancer

This trial studies a special PET/CT scan called FAPI PET/CT to see how well it can detect or track cancerous tumors. It may help doctors better understand your cancer without extra procedures.

Hefei, Anhui
NCT06690970Recruiting
PSMA PET/CT scan for people with or suspected to have cancer

This study is looking at how well a special type of PET/CT scan (called PSMA PET/CT) can see cancer in people who have or may have certain tumors. It may help doctors better understand and track the disease.

Hefei, Anhui
NCT05636540Recruiting· Early Phase 1
PET/CT scan test for a tumor protein in these rare tumors

This early study uses a special PET/CT scan to see how much a specific cancer-related protein (PARP-1) is present in pheochromocytoma and paraganglioma. It may help doctors understand the biology of these tumors and how useful this scan could be in the future.

Philadelphia, Pennsylvania
NCT04111588Recruiting
PET/MRI scan to assess brain tumors and metastases

This trial tests how well a special PET/MRI scan can help doctors evaluate gliomas and brain metastases. It may help improve diagnosis and treatment planning by comparing scan results with tissue samples or surgery findings.

Bergen
NCT04499365Recruiting· Early Phase 1
PET scan for detecting different cancer types

This trial uses a special PET scan to see how well it can find and track different types of cancer. It may help doctors better understand your cancer.

Fuzhou, Fujian

Hear when a new Primary Hyperparathyroidism trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.